J-j Patard

Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: July 26, 2017

Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: December 24, 2015

Neoadjuvant targeted therapies in renal cell carcinoma

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: August 26, 2015

Renal angiomyolipoma with inferior vena cava thrombosis during pregnancy

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: September 12, 2014

Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: April 18, 2014

Surgical management of locally advanced and metastatic renal cancer: neoadjuvant and adjuvant strategies.

Journal: Minerva urologica e nefrologica = The Italian journal of urology and nephrology

Published: April 12, 2014

CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: February 04, 2014

Incidence and mortality of urological cancers in 2012 in France

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: February 04, 2014

Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?

Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Published: October 28, 2013

Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.

Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.

Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience

Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience

Neoadjuvant targeted therapies in renal cell carcinoma

Neoadjuvant targeted therapies in renal cell carcinoma

Renal angiomyolipoma with inferior vena cava thrombosis during pregnancy

Renal angiomyolipoma with inferior vena cava thrombosis during pregnancy

Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency

Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency

Surgical management of locally advanced and metastatic renal cancer: neoadjuvant and adjuvant strategies.

Surgical management of locally advanced and metastatic renal cancer: neoadjuvant and adjuvant strategies.

CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers

CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers

Incidence and mortality of urological cancers in 2012 in France

Incidence and mortality of urological cancers in 2012 in France

Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?

Should we propose a systematic second transurethral resection of the bladder for all high-risk non-muscle invasive bladder cancers?

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma.

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma.

Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma

Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.